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background:  Acute myocardial infarction (AMI) is one of the major cause of mortality worldwide. Percutaneous coronary intervention (PCI) for AMI 
is a useful non-surgical method. But, the sudden restoring blood flow to the ischemic myocardium can result in ischemia/reperfusion injury. Ischemic 
postconditioning (IPoC) for patients with AMI was first introduced to attenuate ischemia/reperfusion injury in 2005. Then, several clinical trials of 
IPoC were reported. This meta-analysis aims to explore the efficacy and safety of IPoC for patients with AMI.
methods: We searched the Cochrane, PubMed, EMBase, CNKI and Clinical Trials. Randomized controlled trials on IPoC were included, the duplicate 
and the article which failed to present necessary data were excluded. Two authors assessed the quality of the study included independently and the 
extracted data. Data was analyzed under the software of Revman 5.2.
results: 18 randomized controlled trials with a total of 1,131 patients were included. The infarct size in the IPoC group was lower than the 
conventional PCI group at 6 months follow-up [standardized mean difference (SMD): -8.35, 95% Confidence Interval (CI): -11.18 to -5.87, P<0.01, 
I2<25%]. Left ventricular ejection fraction in the IPoC group were increased than the conventional PCI group at 6 months after IPoC (SMD: 0.41, 
95%CI: 0.14-0.68, P<0.01, I2>50%). The all-cause mortality was reported in 5 studies. At 7 days follow-up: RR(combined) = 0.99, 95%CI: 0.95-1.04; 
6 months follow-up: RR(combined) =1.02, 95%CI: 0.95-1.09; ≥ 12 months follow-up: RR(combined) = 0.98, 95%CI: 0.94-1.02. In short-term and 
long-term follow-up, there was no significant difference on all-cause mortality between IPoC and conventional PCI for AMI.
Conclusion: Available evidence from this meta-analysis suggests that IPoC may confer cardio-protection in terms of reducing infarct size and 
improving left ventricular ejection fraction. But, it was no significant difference on all-cause mortality between IPoC and conventional PCI. Future 
studies should focus on the mortality in high-quality, large-scale clinical trials with long-term follow-up.
